A research team at Academia Sinica has developed a key reagent for a pioneering rapid screening test for the COVID-19 coronavirus disease and the technology has been transferred to seven companies, one or two of which will be chosen for possible mass production, James Liao (廖俊智), president of Taiwan's most prestigious research institution, said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close higher on thin turnover ahead of Fed decision
09/16/2026 03:33 PM - Business
TSMC returns to prior ex-dividend level within 27 minutes after opening
09/16/2026 03:08 PM - Society
Labor groups urge uniform penalties for minimum wage violations
09/16/2026 03:03 PM - Politics
Presidential Office to hold forum on Taiwan's whole-of-society resilience
09/16/2026 02:32 PM - Society
Chiayi tries to sell public on new Mid-Autumn delicacy: Crocodile leg
09/16/2026 02:16 PM